ZYMEWORKS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.2 USD | +2.22% |
|
+11.38% | -11.45% |
| May. 02 | Transcript : Zymeworks Inc., Q1 2024 Earnings Call, May 02, 2024 | |
| May. 02 | Zymeworks Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 1,793 | 2,171 | 763 | 506.3 | 727.3 | 655.7 | - | - |
| Enterprise Value (EV) 1 | 1,494 | 1,929 | 561.2 | 506.3 | 569.8 | 580.3 | 580 | 655.7 |
| P/E ratio | -11.9 x | -13.2 x | -3.99 x | 4.14 x | -6.04 x | -6.74 x | -5.51 x | -6.23 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 60.7 x | 55.7 x | 28.6 x | 1.23 x | 9.57 x | 7.98 x | 5.85 x | 5.1 x |
| EV / Revenue | 50.6 x | 49.5 x | 21 x | 1.23 x | 7.5 x | 7.06 x | 5.17 x | 5.1 x |
| EV / EBITDA | -10.2 x | -10.7 x | -2.68 x | 3.68 x | -4.46 x | -3.98 x | -3.95 x | -4.44 x |
| EV / FCF | -16.9 x | -12.4 x | -2.74 x | - | -4.72 x | -5.98 x | -3.72 x | - |
| FCF Yield | -5.9% | -8.07% | -36.5% | - | -21.2% | -16.7% | -26.9% | - |
| Price to Book | 7.32 x | 5.81 x | 3.07 x | - | - | - | - | - |
| Nbr of stocks (in thousands) | 39,438 | 45,946 | 46,554 | 64,414 | 70,002 | 71,276 | - | - |
| Reference price 2 | 45.46 | 47.26 | 16.39 | 7.860 | 10.39 | 9.200 | 9.200 | 9.200 |
| Announcement Date | 3/2/20 | 2/24/21 | 2/24/22 | 3/7/23 | 3/6/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 29.54 | 38.95 | 26.68 | 412.5 | 76.01 | 82.17 | 112.2 | 128.7 |
| EBITDA 1 | -145.9 | -180 | -209.1 | 137.8 | -127.9 | -145.8 | -146.8 | -147.8 |
| EBIT 1 | -150.5 | -187.5 | -215.6 | 130.5 | -138.1 | -148.2 | -138.3 | - |
| Operating Margin | -509.52% | -481.29% | -808.22% | 31.64% | -181.62% | -180.4% | -123.31% | - |
| Earnings before Tax (EBT) 1 | -146 | -180.1 | -212.4 | 135.2 | -119.2 | -120.4 | -78 | -54.23 |
| Net income 1 | -145.4 | -180.6 | -211.8 | 124.3 | -118.7 | -102.2 | -78 | -54.23 |
| Net margin | -492.27% | -463.54% | -794.01% | 30.14% | -156.13% | -124.38% | -69.54% | -42.14% |
| EPS 2 | -3.830 | -3.580 | -4.110 | 1.900 | -1.720 | -1.365 | -1.671 | -1.477 |
| Free Cash Flow 1 | -88.18 | -155.7 | -204.9 | - | -120.8 | -97 | -156 | - |
| FCF margin | -298.45% | -399.77% | -767.82% | - | -158.89% | -118.04% | -139.08% | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Announcement Date | 3/2/20 | 2/24/21 | 2/24/22 | 3/7/23 | 3/6/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 19.87 | 1.916 | 5.442 | 2.631 | 402.5 | 35.58 | 7.002 | 16.51 | 16.93 | 10.03 | 15 | 13.55 | 43.67 |
| EBITDA 1 | -39.85 | -70.22 | -64.29 | - | - | - | - | - | -21.21 | - | -36.05 | -37 | -37.72 |
| EBIT 1 | -40.85 | -72.69 | -65.82 | -50.36 | 319.4 | -27.28 | -54.11 | -33.24 | -23.42 | -37.8 | -35.47 | -35.67 | -34.43 |
| Operating Margin | -205.58% | -3,793.63% | -1,209.54% | -1,914.03% | 79.35% | -76.68% | -772.84% | -201.36% | -138.37% | -376.89% | -236.47% | -263.23% | -78.85% |
| Earnings before Tax (EBT) 1 | -40.52 | -72.7 | -64.63 | -47.88 | 320.4 | -22.96 | -49.5 | -27.58 | -19.2 | -31.58 | -30.23 | -33.07 | -39.39 |
| Net income 1 | -39.15 | -72.62 | -64.62 | -47.85 | 309.4 | -24.35 | -51.15 | -28.69 | -14.48 | -31.65 | -25.94 | -31.83 | -26.48 |
| Net margin | -197.04% | -3,790.45% | -1,187.41% | -1,818.55% | 76.88% | -68.45% | -730.53% | -173.8% | -85.56% | -315.58% | -172.91% | -234.87% | -60.64% |
| EPS 2 | -0.7600 | -1.190 | -0.9700 | -0.7200 | 4.650 | -0.3600 | -0.7600 | -0.4100 | -0.2000 | -0.4200 | -0.3400 | -0.4725 | -0.3436 |
| Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 2/24/22 | 5/4/22 | 8/4/22 | 11/8/22 | 3/7/23 | 5/8/23 | 8/10/23 | 11/7/23 | 3/6/24 | 5/2/24 | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | 299 | 242 | 202 | - | 158 | 75.4 | 75.8 | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | -88.2 | -156 | -205 | - | -121 | -97 | -156 | - |
| ROE (net income / shareholders' equity) | -68.3% | -55.1% | -64.3% | - | -24.8% | -30.5% | -46.5% | -58.9% |
| ROA (Net income/ Total Assets) | -47.5% | -39.8% | -45.7% | - | -19.3% | -20.8% | -31.7% | - |
| Assets 1 | 306.3 | 453.3 | 463.8 | - | 614.8 | 492.2 | 246.2 | - |
| Book Value Per Share | 6.210 | 8.140 | 5.340 | - | - | - | - | - |
| Cash Flow per Share | -2.150 | - | - | - | - | - | - | - |
| Capex 1 | 6.32 | 4.31 | 12.4 | - | 2.47 | 6.5 | 10 | 1 |
| Capex / Sales | 21.4% | 11.07% | 46.49% | - | 3.25% | 7.91% | 8.92% | 0.78% |
| Announcement Date | 3/2/20 | 2/24/21 | 2/24/22 | 3/7/23 | 3/6/24 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
9.2
USD
Average target price
13.72
USD
Spread / Average Target
+49.15%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -11.45% | 656M | |
| +8.96% | 105B | |
| -1.43% | 104B | |
| +4.40% | 22.94B | |
| -12.15% | 22.34B | |
| -4.36% | 19.25B | |
| -39.98% | 17.08B | |
| -10.04% | 16.96B | |
| +38.61% | 12.63B | |
| +313.59% | 8.49B |
- Stock Market
- Equities
- ZYME Stock
- Financials Zymeworks Inc.
